AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
$16.65 -0.56 (-3.2539%)
Analysed AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) News Sources
Aurinia’s (AUPH) Profits Surge While Its One Drug Just Got Company
16-09-2026
yahoo.com
Earnings Preview: Ionis Pharmaceuticals (IONS) Q3 Earnings Expected to Decline
28-10-2026
yahoo.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
06-07-2026
yahoo.com
AUPH Stock Rallies 6% After-Hours — Here’s Why
19-08-2026
stocktwits.com
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
29-06-2026
yahoo.com
How Investors Are Reacting To Aurinia Pharmaceuticals (AUPH) Extended Voclosporin Exclusivity And Share Buyback
20-08-2026
yahoo.com
Earnings Preview: Aurinia Pharmaceuticals (AUPH) Q3 Earnings Expected to Decline
27-10-2026
yahoo.com
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
30-10-2026
yahoo.com
Aurinia: Q3 Earnings Snapshot
30-10-2026
yahoo.com
Aurinia Pharmaceuticals (AUPH) Tops Q3 Earnings Estimates
30-10-2026
yahoo.com
What is the current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is $16.65.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is $-0.56.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is -3.2539%.
What is the most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is .
SEC-8K** Filing Available For AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.